Seeking Alpha

Oramed Pharmaceuticals (ORMP +1%) gains after receiving approval for a key patent by the...

Oramed Pharmaceuticals (ORMP +1%) gains after receiving approval for a key patent by the Japanese Patent Office. The patent, which has also been approved in Israel and Australia, is titled "Methods and Compositions for Oral Administrations of Proteins," and covers a core concept of the company's technology. ORMP's portfolio now consists of seven issued patents with 28 patents pending.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector